Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetes.
2型糖尿病
brachial-ankle pulse wave velocity (baPWV)
cardiovascular disease (CVD)
estimated glomerular filtration rate (eGFR)
metabolic goal
type 2 diabetes
urinary albumin-to-creatinine ratio (UACR)
代谢目标
估计肾小球滤过率(eGFR)
尿白蛋白/肌酐比值(UACR)
心血管疾病
臂-踝脉搏波传导速度(BaPWV)
Journal
Journal of diabetes
ISSN: 1753-0407
Titre abrégé: J Diabetes
Pays: Australia
ID NLM: 101504326
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
02
03
2022
received:
05
12
2021
accepted:
28
03
2022
pubmed:
6
5
2022
medline:
28
5
2022
entrez:
5
5
2022
Statut:
ppublish
Résumé
To investigate the arterial stiffness (AS) risk within urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) categories and the joint effect between kidney disease parameters and metabolic goal achievement on AS risk in adult people with type 2 diabetes (T2D). A total of 27 439 Chinese participants with T2D from 10 National Metabolic Management Centers (MMC) were categorized into four albuminuria/decreased eGFR groups. The criteria for decreased eGFR and AS were eGFR <90 ml/min/1.73 m After full adjustment, odds ratios (ORs) for AS were highest for albuminuria and decreased eGFR (2.23 [1.98-2.52]) and were higher for albuminuria and normal eGFR (1.52 [1.39-1.67]) than for those with nonalbuminuria and decreased eGFR (1.17 [1.04-1.32]). Both UACR and eGFR in the subgroup or overall population independently correlated with AS risk. The achievement of ≥2 metabolic goals counteracted the association between albuminuria and AS risk (OR: 0.93; 95% CI: 0.80-1.07; p = .311). When the metabolic goals added up to ≥2 for patients with decreased eGFR, they showed significantly lower AS risk (OR: 0.65; 95% CI: 0.56-0.74; p < .001). Both higher UACR and lower eGFR are determinants of AS risk, with UACR more strongly related to AS than eGFR in adults with T2D. The correlation between albuminuria/decreased eGFR and AS was modified by the achievement of multiple metabolic elements. 背景: 探讨成人2型糖尿病(T2D)患者尿白蛋白/肌酐(UACR)和估计肾小球滤过率(eGFR)两类指标对动脉硬化(AS)风险的影响, 以及肾脏疾病和代谢目标实现程度对AS风险的联合影响。 方法: 将来自10个国家代谢管理中心(MMC)的27439名T2D受试者分为4个白蛋白尿/eGFR降低组。以eGFR<90ml/min/1.73m
Sections du résumé
BACKGROUND
BACKGROUND
To investigate the arterial stiffness (AS) risk within urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) categories and the joint effect between kidney disease parameters and metabolic goal achievement on AS risk in adult people with type 2 diabetes (T2D).
METHODS
METHODS
A total of 27 439 Chinese participants with T2D from 10 National Metabolic Management Centers (MMC) were categorized into four albuminuria/decreased eGFR groups. The criteria for decreased eGFR and AS were eGFR <90 ml/min/1.73 m
RESULTS
RESULTS
After full adjustment, odds ratios (ORs) for AS were highest for albuminuria and decreased eGFR (2.23 [1.98-2.52]) and were higher for albuminuria and normal eGFR (1.52 [1.39-1.67]) than for those with nonalbuminuria and decreased eGFR (1.17 [1.04-1.32]). Both UACR and eGFR in the subgroup or overall population independently correlated with AS risk. The achievement of ≥2 metabolic goals counteracted the association between albuminuria and AS risk (OR: 0.93; 95% CI: 0.80-1.07; p = .311). When the metabolic goals added up to ≥2 for patients with decreased eGFR, they showed significantly lower AS risk (OR: 0.65; 95% CI: 0.56-0.74; p < .001).
CONCLUSIONS
CONCLUSIONS
Both higher UACR and lower eGFR are determinants of AS risk, with UACR more strongly related to AS than eGFR in adults with T2D. The correlation between albuminuria/decreased eGFR and AS was modified by the achievement of multiple metabolic elements.
背景: 探讨成人2型糖尿病(T2D)患者尿白蛋白/肌酐(UACR)和估计肾小球滤过率(eGFR)两类指标对动脉硬化(AS)风险的影响, 以及肾脏疾病和代谢目标实现程度对AS风险的联合影响。 方法: 将来自10个国家代谢管理中心(MMC)的27439名T2D受试者分为4个白蛋白尿/eGFR降低组。以eGFR<90ml/min/1.73m
Autres résumés
Type: Publisher
(chi)
背景: 探讨成人2型糖尿病(T2D)患者尿白蛋白/肌酐(UACR)和估计肾小球滤过率(eGFR)两类指标对动脉硬化(AS)风险的影响, 以及肾脏疾病和代谢目标实现程度对AS风险的联合影响。 方法: 将来自10个国家代谢管理中心(MMC)的27439名T2D受试者分为4个白蛋白尿/eGFR降低组。以eGFR<90ml/min/1.73m
Identifiants
pubmed: 35510608
doi: 10.1111/1753-0407.13269
pmc: PMC9366591
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-355Informations de copyright
© 2022 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.
Références
Diabetes Care. 2011 May;34(5):e53; author reply e54
pubmed: 21525493
Am J Hypertens. 2015 Aug;28(8):958-65
pubmed: 25687879
J Am Soc Nephrol. 2005 Apr;16(4):1069-75
pubmed: 15743996
Circulation. 2004 Jan 20;109(2):184-9
pubmed: 14662706
Cardiovasc Diabetol. 2021 Apr 22;20(1):82
pubmed: 33888131
Front Cell Dev Biol. 2019 Dec 03;7:314
pubmed: 31850348
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Am Soc Nephrol. 2005 Apr;16(4):1141-8
pubmed: 15743997
Diabetes Care. 1998 Dec;21(12):2191-2
pubmed: 9839117
J Diabetes. 2022 May;14(5):345-355
pubmed: 35510608
Am J Hypertens. 2016 Sep;29(9):1038-45
pubmed: 27068705
J Am Soc Nephrol. 2007 Jun;18(6):1942-52
pubmed: 17460143
Nephrol Dial Transplant. 2021 Jan 25;36(2):281-288
pubmed: 31532488
Am J Kidney Dis. 2019 Feb;73(2):240-247
pubmed: 29908694
Am J Kidney Dis. 2010 Jan;55(1):21-30
pubmed: 19765871
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25
pubmed: 26028594
Kidney Int. 2004 Jul;66(1):448-54
pubmed: 15200455
Am J Kidney Dis. 2018 Nov;72(5):682-690
pubmed: 30007506
J Hum Hypertens. 2005 Jun;19(6):439-44
pubmed: 15660121
Diabetes Care. 2015 May;38(5):905-12
pubmed: 25710922
J Am Soc Nephrol. 2009 Sep;20(9):2044-53
pubmed: 19608701
Diabetes Care. 2000 Aug;23(8):1108-12
pubmed: 10937506
Curr Med Res Opin. 2003;19(1):22-7
pubmed: 12661776
Circulation. 1983 Jul;68(1):50-8
pubmed: 6851054
BMJ Open Diabetes Res Care. 2020 Oct;8(1):
pubmed: 33087340
Nephrol Dial Transplant. 2011 Sep;26(9):2820-7
pubmed: 21335440
J Diabetes. 2019 Jan;11(1):11-13
pubmed: 30284373
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
PLoS One. 2019 Feb 4;14(2):e0210522
pubmed: 30716076
Ann Biol Clin (Paris). 2018 Feb 1;77(1):26-35
pubmed: 30799295
Hypertens Res. 2003 Aug;26(8):615-22
pubmed: 14567500
Diabet Med. 1992 Mar;9(2):114-9
pubmed: 1563244
Atherosclerosis. 2010 Jul;211(1):315-21
pubmed: 20226463
Curr Hypertens Rep. 2004 Dec;6(6):436-41
pubmed: 15527687
Diabetes Care. 2020 Jan;43(1):122-129
pubmed: 31796570
J Formos Med Assoc. 2018 Aug;117(8):662-675
pubmed: 29486908